Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir

References

• Florence AT, Omotosho JA, Whateley TL. (1989). Multiple w/o/w emulsions as drug vehicles. In: Rosoff M, ed. Controlled release of drugs: polymers and aggregate systems. VCH Publishers, Marcel Dekker, 163–184.
   Google Scholar
• Koga K, Takarada N, Takada K. (2010). Nano-sized water-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compound. Eur J Pharm Biopharm, 74:223–232.
   PubMed Web of Science ®Google Scholar
• Onuki Y, Morishita M, Takayama K. (2004). Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J Control Release, 97:91–99.
   PubMed Web of Science ®Google Scholar
• Nakhare S, Vyas SP. (1995). Prolonged release multiple emulsion based system bearing rifampicin: in vitro characterisation. Drug Dev Ind Pharm, 21(7):869–878.
   Web of Science ®Google Scholar
• Tang SY, Sivakumar M. (2012). Design and evaluation of aspirin-loaded water-in-oil-in-water submicron multiple emulsions generated using two-stage ultrasonic cavitational emulsification technique. Asia-Pacific J Chem Eng, 7(S1):S145–S156.
   Web of Science ®Google Scholar
• Ghosh LK, Ghosh NC, Thakur RS, Pal M, Gupta BK (1997). Design and evaluation of controlled-release W/O/W multiple-emulsion oral liquid delivery system of chlorpheniramine maleate. Drug Dev Ind Pharm, 23(11):1131–1134.
   Web of Science ®Google Scholar
• Sharma G, Wilson K, van der Walle CF, Sattar N, Petrie JR, Ravi Kumar MN. (2010). Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm, 76:159–169.
   PubMed Web of Science ®Google Scholar
• Morishita M, Matsuzawa A, Takaynama K, Isowa K, Nagai T. (1998). Improving insulin enteral absorption using w/o/w emulsion. Int J Pharm, 172:189–198.
   Web of Science ®Google Scholar
• Shively ML, Thompson DC. (1995). Oral bioavailability of vancomycin solid emulsion. Int J Pharm, 117:119–122.
   Web of Science ®Google Scholar
• Wang Y, Shan C, Ming S, Liu Y, Du Y, Jiang G. (2009). Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res Vet Sci, 86:399–405.
   PubMed Web of Science ®Google Scholar
• Bozkir A, Hayta G. (2004). Preparation and evaluation of multiple emulsions water-in-oil-in-water (w/o/w) as delivery system for influenza virus antigens. J Drug Target, 12:157–164.
   PubMed Web of Science ®Google Scholar
• Taylor PJ, Miller CL, Pollock TM, Perkins FT, Westwood MA. (1969). Antibody response and reaction to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. J Hyg, 67:485–490.
   PubMedGoogle Scholar
• Jiao J, Rhodes DG, Burgess DJ. (2002). Multiple emulsion stability: pressure balance and interfacial film strength. J Colloid Interface Sci, 250:444–450.
   PubMed Web of Science ®Google Scholar
• Chiang CW, Fuller GC, Frankenfeld JW, Rhodes CT. (1978). Potential of liquid membranes for drug overdose treatment: in vitro studies. J Pharm Sci, 67:63–66.
   PubMed Web of Science ®Google Scholar
• Garti N, Benichou A. (2004). Recent developments in double emulsions for food applications. In: Friberg S, Larsson K, Sjoblom J, eds. Food Emulsions, 4th edn. New York: Marcel Dekker, 353–412.
   Google Scholar
• Sohi H, Sultana Y, Khar RK. (2004). Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm, 30:429–448.
   PubMed Web of Science ®Google Scholar
• Oh C, Lee JH, Lee YG, Lee YH, Kim JW, Kang HH et al. (2006). New approach to the immobilization of glucose oxidase on non-porous silica microspheres functionalized by (3-aminopropyl)trimethoxysilane (APTMS). Colloids Surf B Biointerfaces, 53:225–232.
   PubMed Web of Science ®Google Scholar
• May SW, Li NN. (1972). The immobilization of urease using liquid-surfactant membranes. Biochem Biophys Res Commun, 47:1179–1185.
   PubMed Web of Science ®Google Scholar
• Omotosho JA, Florence AT, Whateley TL. (1990). Absorption and lymphatic uptake of 5-FU in the rat following oral administration of w/o/w multiple emulsion. Int J Pharm, 61:51–56.
   Web of Science ®Google Scholar
• Florence AT, Whitehill D. (1982). The formulation and stability of multiple emulsions. Int J Pharm, 11:277–308.
   Web of Science ®Google Scholar
• Araya H, Tomita M, Hayashi M. (2005). The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds. Int J Pharm, 305:61–74.
   PubMed Web of Science ®Google Scholar
• Tolle-Sander S, Lentz KA, Maeda DY, Coop A, Polli JE. (2004). Increased acyclovir oral bioavailability via a bile acid conjugate. Mol Pharm, 1:40–48.
   PubMed Web of Science ®Google Scholar
• de Miranda P, Blum MR. (1983). Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother, 12 Suppl B:29–37.
   PubMed Web of Science ®Google Scholar
• Freeman DJ, Sheth NV, Spruance SL. (1986). Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother, 29:730–732.
   PubMed Web of Science ®Google Scholar
• Jain SK, Jain RK, Chourasia MK, Jain AK, Chalasani KB, Soni V et al. (2005). Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS PharmSciTech, 6:E35–E41.
   PubMed Web of Science ®Google Scholar
• Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP et al. (1998). 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res, 15:1154–1159.
   PubMed Web of Science ®Google Scholar
• Bundgaard H, Jensen E, Falch E. (1991). Water-soluble, solution-stable, and biolabile N-substituted (aminomethyl)benzoate ester prodrugs of acyclovir. Pharm Res, 8:1087–1093.
   PubMed Web of Science ®Google Scholar
• Shao Z, Park GB, Krishnamoorthy R, Mitra AK. (1994). The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2′-ester prodrugs. Pharm Res, 11:237–242.
   PubMed Web of Science ®Google Scholar
• Chikhale PJ, Venkatraghavan V, Bodor NS. (1996). Improved delivery through biological membranes LX: Intradermal targeting of acyclovir using redox-based chemical drug delivery systems. Drug Delivery, 3:17–26.
   Google Scholar
• Krenitsky TA, Hall WW, de Miranda P, Beauchamp LM, Schaeffer HJ, Whiteman PD. (1984). 6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir. Proc Natl Acad Sci USA, 81:3209–3213.
   PubMed Web of Science ®Google Scholar
• Smiley ML. (1993). Valciclovir and acyclovir for the treatment of recurrent genital herpes simplex infections. Intersci Conf Antimicrob Chemother, 33:1210.
   Google Scholar
• Rossi S. (2006). Australian Medicines Handbook. Adelaide: Australian Medicines.
   Google Scholar
• Shojaei AH, Zhuo SL, Li X. (1998). Transbuccal delivery of acyclovir (II): feasibility, system design, and in vitro permeation studies. J Pharm Pharm Sci, 1:66–73.
   PubMedGoogle Scholar
• Law SL, Huang KJ, Chiang CH. (2000). Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J Control Release, 63:135–140.
   PubMed Web of Science ®Google Scholar
• Gandhi P, Momin N, Kharade S, Konapure NP, Kuchekar BS. (2006). Spectrophotometric estimation of acyclovir in pharmaceutical dosage forms. Indian J Pharm Sci, 68(4):516–517.
   Google Scholar
• Hino T, Takeuchi H, Niwa T, Kitagawa M, Kawashima Y. (1995). The analysis of drug release from diluted w/o/w emulsions by a model of the rupture of oil membrane. J Pharm Pharmacol, 47:1–7.
   Web of Science ®Google Scholar
• Bangaru RA, Bansal YK, Rao AR, Gandhi TP. (2000). Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies. J Chromatogr B Biomed Sci Appl, 739:231–237.
   PubMed Web of Science ®Google Scholar
• Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ et al. (1998). Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release, 50:31–40.
   PubMed Web of Science ®Google Scholar
• Geiger S, Tokgoz S, Fructus A, Jager-Lezer N, Seiller M, Lacombe C et al. (1998). Kinetics of swelling-breakdown of a W/O/W multiple emulsion: possible mechanisms for the lipophilic surfactant effect. J Control Release, 52:99–107.
   PubMed Web of Science ®Google Scholar
• Tirnaksiz F, Kalsin O. (2005). A topical w/o/w multiple emulsions prepared with Tetronic 908 as a hydrophilic surfactant: formulation, characterization and release study. J Pharm Pharm Sci, 8:299–315.
   PubMed Web of Science ®Google Scholar
• Terrisse I, Seiller M, Rabaron A, Grossiord JL, Magnet A, Hen-Ferrenbach C. (1993). Rheology: how to characterize and to predict the evolution of W/O/W multiple emulsions. Int J Cosmet Sci, 15:53–62.
   PubMedGoogle Scholar
• Fredro-Kumbaradzi E, Popovska-Pavlovska F, Simov A, Goracinova K, Glavas M, Mladenovska K. (1998). Formulation and release of lidocaine HCl from multiple w/o/w emulsions. Glas Hem Tehnol Maked 17(2):119–123.
   Google Scholar
• Adeyeye CM, Price JC. (1990). Effect of dextrose in the internal aqueous phase on formation and stability of w/o/w multiple emulsion. Drug Dev Ind Pharm, 16(6):1053–1071.
   Web of Science ®Google Scholar
• Pays K, Giermanska-Kahn J, Pouligny B, Bibette J, Leal-Calderon F. (2002). Double emulsions: how does release occur? J Control Release, 79:193–205.
   PubMed Web of Science ®Google Scholar